Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Biotech news today july 29 2025?What is the most recent public date tied to reaching or confirming the highest us phase for amphadase?Cilostazol production cost?Patent abrocitinib example 2 u's pat no 9 035 074?Does medicare cover viokace?
See the DrugPatentWatch profile for Dofetilide
Dofetilide is an antiarrhythmic medication classified as a Class III antiarrhythmic (it blocks the cardiac potassium current that helps control cardiac repolarization).
Class III antiarrhythmics mainly act by prolonging cardiac repolarization (and often the effective refractory period), which helps slow the electrical recovery time between beats—an effect used to treat certain atrial arrhythmias.
Dofetilide is used for rhythm control in atrial arrhythmias, including atrial fibrillation and atrial flutter, and it may help maintain sinus rhythm.
A key concern is proarrhythmia, especially risk of torsades de pointes (a potentially life-threatening ventricular rhythm). This risk is closely tied to how the drug affects repolarization, and it drives careful dosing and monitoring requirements.
You can track background and proprietary/market information for dofetilide via DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Dofetilide :